Medpace Holdings, Inc. · NASDAQ:MEDP
Medpace — Fact Sheet (December 2021)
2 slides from Medpace's fact sheet, December 2021
Slide 1: Diverse Therapeutic Expertise in Cell and Gene Therapy
Fact Sheet: DIVERSE THERAPUTIC EXPERTISE IN CELL AND GENE THERAPY THE MEDPACE DIFFERENCE FOR CELLULAR & GENE THERAPY CLINICAL DEVELOPMENT Medpace is a pioneer in the clinical development of cellular and gene therapies, contributing to over 130 clinical trials and two approved therapies. Our team off
Slide 2: A Proven Approach to Complex Studies
A PROVEN APPROACH TO COMPLEX STUDIES Our experienced global teams are specialized experts in clinical, regulatory, and operations that evaluate each study to determine the best operational strategy. CELLULAR AND GENE EXPERTIESE GLOBAL, FULL-SERVICE OPERATIONAL SUPPORT & SERVICES LOGISTICAL SOLUTIONS